Bio-Rad Laboratories Inc. (BIO.B) on Wednesday reported a third-quarter loss of $341.9 million, after reporting a profit in the same period a ...

The outlook for full year 2025 remains unchanged at flat to 1% currency-neutral revenue growth, consistent with the Q2 update. Margins guidance is also unchanged. Q3 reported a slight revenue and ...

The company doesn't seem like it will generate pops in key fundamentals anytime soon.

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the ...

The Model 422 electro-eluter is an electroelution cell for preparative recovery of biomolecules from agarose and acrylamide gels. The eluter combines with the tank and lid of the Mini Trans-Blot® cell ...

The firm is projecting a gradual recovery of the academic market in the face of ongoing funding uncertainties and a government shutdown.

The challenges facing biotechs amid the ongoing financial fallout have resulted in the winding down of one US biotech, Vor Bio, and job losses at a clutch of other firms. Cambridge, ...

Sanofi says it has reached an agreement with Dren Bio that would see it take control of autoimmune disease treatment DR-0201, a bispecific antibody-based myeloid cell engager with the potential to ...

Bioinspired materials are synthetic materials whose structure, properties or function mimic those of natural materials or living matter. Examples of bioinspired materials are light-harvesting photonic ...

His mother believes Halloween “brings out the devil,” so husband wants to keep their baby’s lion costume a secret. Fiancé’s “shallow” family will judge him if they find out the letter writer’s ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.